Patents by Inventor Anuoluwapo Osinusi

Anuoluwapo Osinusi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING SARS COV-2 INFECTIONS
    Publication number: 20230346812
    Abstract: Provided are methods for treating 2019-nCoV virus (SARS-CoV-2) infections by administering nucleosides and prodrugs thereof, of Formula I: wherein the 1? position of the nucleoside sugar is substituted.
    Type: Application
    Filed: April 5, 2023
    Publication date: November 2, 2023
    Inventors: Tomas Cihlar, Anuoluwapo Osinusi, Danielle L. Porter
  • Methods for treating SARS CoV-2 infections
    Patent number: 11660307
    Abstract: Provided are methods for treating 2019-nCoV virus (SARS-CoV-2) infections by administering nucleosides and prodrugs thereof, of Formula I: wherein the 1? position of the nucleoside sugar is substituted.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: May 30, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Tomas Cihlar, Anuoluwapo Osinusi, Danielle L. Porter
  • METHODS FOR TREATING SARS COV-2 INFECTIONS
    Publication number: 20210283150
    Abstract: Provided are methods for treating 2019-nCoV virus (SARS-CoV-2) infections by administering nucleosides and prodrugs thereof, of Formula I: wherein the 1? position of the nucleoside sugar is substituted.
    Type: Application
    Filed: January 26, 2021
    Publication date: September 16, 2021
    Inventors: Tomas Cihlar, Anuoluwapo Osinusi, Danielle L. Porter